HCA Healthcare, Inc. (NYSE:HCA) is Intech Investment Management LLC’s 9th Largest Position

Intech Investment Management LLC lifted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 63.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 276,269 shares of the company’s stock after purchasing an additional 106,986 shares during the quarter. HCA Healthcare accounts for approximately 2.5% of Intech Investment Management LLC’s holdings, making the stock its 9th biggest position. Intech Investment Management LLC owned approximately 0.11% of HCA Healthcare worth $82,922,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of HCA. GSA Capital Partners LLP purchased a new position in HCA Healthcare in the 3rd quarter worth about $567,000. Natixis Advisors LLC raised its position in HCA Healthcare by 2.3% in the 3rd quarter. Natixis Advisors LLC now owns 110,105 shares of the company’s stock worth $44,750,000 after buying an additional 2,459 shares during the last quarter. Atlanta Consulting Group Advisors LLC bought a new stake in shares of HCA Healthcare during the 3rd quarter valued at about $311,000. Planning Directions Inc. bought a new stake in shares of HCA Healthcare during the 3rd quarter valued at about $236,000. Finally, Quest Partners LLC grew its stake in shares of HCA Healthcare by 384.9% during the 3rd quarter. Quest Partners LLC now owns 3,171 shares of the company’s stock valued at $1,289,000 after purchasing an additional 2,517 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Up 2.9 %

NYSE:HCA opened at $328.73 on Tuesday. The company has a market cap of $80.94 billion, a price-to-earnings ratio of 14.96, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The stock has a fifty day simple moving average of $319.64 and a 200-day simple moving average of $344.49.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter last year, the company earned $5.90 EPS. Analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.88%. The ex-dividend date is Monday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s payout ratio is 13.11%.

Analyst Ratings Changes

A number of research analysts recently issued reports on the company. KeyCorp cut their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. Bank of America cut their price objective on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research note on Monday, January 27th. Barclays cut their price objective on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research note on Monday, January 27th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $380.00 price target on shares of HCA Healthcare in a research note on Tuesday, December 17th. Finally, Raymond James downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $385.67.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.60% of the stock is owned by insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.